GSK partners with Government on quadrivalent flu jab

flu virus in pink
GSK Australia is partnering with the Australian Government to provide a quadrivalent influenza vaccine for the National Immunisation Program for the 2016 season. Fluarix® Tetra is a four-strain flu vaccine indicated for the active immunisation of adults and children from three years of age for the prevention of influenza disease caused by the influenza virus

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous New survey identifies real food poisoning culprits
Next Hunt for dementia genes awarded Government funding